Palatin Technologies Inc (PTN)

1.11 +0.12 (+12.12%) USD  |  NYAM  |  Dec 26, 16:00
1.09 -0.02 (-1.80%) Pre-Market: 08:27
More

Palatin Technologies Research and Development Expense (Quarterly): 5.744M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for PTN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
NovaBay Pharmaceuticals Inc 0.004M
iBio Inc 1.305M
Theriva Biologics Inc 2.734M
Oragenics Inc 0.879M
Nanoviricides Inc 1.933M